4//SEC Filing
Viking Therapeutics, Inc. 4
Accession 0001209191-17-030443
$VKTXCIK 0001607678operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 6:25 PM ET
Size
5.3 KB
Accession
0001209191-17-030443
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.00001 per share
2017-05-04$1.34/sh−8,192$10,977→ 80,604 total
Footnotes (2)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock.
- [F2]Includes 147 shares acquired on May 20, 2015 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, 2,643 shares acquired on November 20, 2015 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, 5,694 shares acquired on May 20, 2016 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, and 2,908 shares acquired on November 18, 2016 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001607678
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 6:25 PM ET
- Size
- 5.3 KB